Intravenous IgM-enriched immunoglobulins in critical COVID-19: a multicentre propensity-weighted cohort study

Tim Rahmel, Felix Kraft, Helge Haberl, Ute Achtzehn, Timo Brandenburger, Holger Neb, Dominik Jarczak, Maximilian Dietrich, Harry Magunia, Frieda Zimmer, Jale Basten, Claudia Landgraf, Thea Koch, Kai Zacharowski, Markus A. Weigand, Peter Rosenberger, Roman Ullrich, Patrick Meybohm, Axel Nierhaus, Detlef Kindgen-Milles, Nina Timmesfeld, Michael Adamzik

Open source

DOI: 10.1186/s13054-022-04059-0
Published: 2022-07-07
Container: Critical Care
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s13054-022-04059-0,
  title = {Intravenous IgM-enriched immunoglobulins in critical COVID-19: a multicentre propensity-weighted cohort study},
  author = {Tim Rahmel and Felix Kraft and Helge Haberl and Ute Achtzehn and Timo Brandenburger and Holger Neb and Dominik Jarczak and Maximilian Dietrich and Harry Magunia and Frieda Zimmer and Jale Basten and Claudia Landgraf and Thea Koch and Kai Zacharowski and Markus A. Weigand and Peter Rosenberger and Roman Ullrich and Patrick Meybohm and Axel Nierhaus and Detlef Kindgen-Milles and Nina Timmesfeld and Michael Adamzik},
  year = {2022},
  journal = {Critical Care},
  doi = {10.1186/s13054-022-04059-0},
  url = {https://doi.org/10.1186/s13054-022-04059-0}
}

RIS

TY  - JOUR
TI  - Intravenous IgM-enriched immunoglobulins in critical COVID-19: a multicentre propensity-weighted cohort study
AU  - Tim Rahmel
AU  - Felix Kraft
AU  - Helge Haberl
AU  - Ute Achtzehn
AU  - Timo Brandenburger
AU  - Holger Neb
AU  - Dominik Jarczak
AU  - Maximilian Dietrich
AU  - Harry Magunia
AU  - Frieda Zimmer
AU  - Jale Basten
AU  - Claudia Landgraf
AU  - Thea Koch
AU  - Kai Zacharowski
AU  - Markus A. Weigand
AU  - Peter Rosenberger
AU  - Roman Ullrich
AU  - Patrick Meybohm
AU  - Axel Nierhaus
AU  - Detlef Kindgen-Milles
AU  - Nina Timmesfeld
AU  - Michael Adamzik
PY  - 2022
JO  - Critical Care
DO  - 10.1186/s13054-022-04059-0
UR  - https://doi.org/10.1186/s13054-022-04059-0
ER  -

APA

Rahmel, T., Kraft, F., Haberl, H., Achtzehn, U., Brandenburger, T., Neb, H., Jarczak, D., Dietrich, M., Magunia, H., Zimmer, F., Basten, J., Landgraf, C., Koch, T., Zacharowski, K., Weigand, M. A., Rosenberger, P., Ullrich, R., Meybohm, P., Nierhaus, A., Kindgen-Milles, D., Timmesfeld, N., & Adamzik, M. (2022). Intravenous IgM-enriched immunoglobulins in critical COVID-19: a multicentre propensity-weighted cohort study. Critical Care. https://doi.org/10.1186/s13054-022-04059-0

Source records

crossref · retrieved 2026-09-26T22:49:43.837Z